CD276 and esophageal squamous cell carcinoma: When co-cultured with iPSC-derived CD276-targeted CAR-NK cells at the same dosage from day 1 to day 5 (Figure 2A), the CD276-expressing ESCC PSO experienced significant disintegration and suspension, while the CD276-negative NC PSO persisted and continued to grow during the same period.